[1]
I. . Shahid, “Probable factors impacting the real-world treatment outcomes of direct-acting antivirals for hepatitis C treated populations: A themed review ”, iRASD J. Pharm., vol. 1, no. 1, pp. 01–16, Dec. 2021.